Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54383700)
Watch
English
Afatinib for lung cancer: let there be light?
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
title
Afatinib for lung cancer: let there be light?
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
author
Marina Garassino
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
author name string
Valter Torri
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
publication date
15 January 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
volume
15
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
page(s)
133-134
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
cites work
Management of non-small-cell lung cancer: recent developments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970002-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetics and biomarkers in personalisation of lung cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970002-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Throwing new light on lung cancer pathogenesis: updates on three recent topics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970002-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970002-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970002-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970002-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970002-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(14)70002-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
PubMed publication ID
24439930
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24439930
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24439930%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
